Publications by authors named "Toru Tsutsui"
Article Synopsis
- Recombinant human-soluble thrombomodulin (rhTM) is being investigated for its potential to improve outcomes in sepsis patients experiencing severe respiratory failure due to blood clotting issues.
- A study involving 1,180 patients from 42 ICUs in Japan compared survival rates and ventilator-free days between those treated with rhTM and those who were not.
- Results showed that rhTM treatment was linked to lower ICU and hospital mortality rates, suggesting it may be an effective therapeutic option for these patients.
